Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Current Trends in Macrocyclic Drug Discovery and beyond-Ro5.
Alihodžić S, Bukvić M, Elenkov IJ, Hutinec A, Koštrun S, Pešić D, Saxty G, Tomašković L, Žiher D. Alihodžić S, et al. Among authors: tomaskovic l. Prog Med Chem. 2018;57(1):113-233. doi: 10.1016/bs.pmch.2018.01.002. Epub 2018 Mar 22. Prog Med Chem. 2018. PMID: 29680148 Review.
Macrolactonolides: a novel class of anti-inflammatory compounds.
Tomašković L, Komac M, Makaruha Stegić O, Munić V, Ralić J, Stanić B, Banjanac M, Marković S, Hrvačić B, Čipčić Paljetak H, Padovan J, Glojnarić I, Eraković Haber V, Mesić M, Merćep M. Tomašković L, et al. Bioorg Med Chem. 2013 Jan 1;21(1):321-32. doi: 10.1016/j.bmc.2012.10.036. Epub 2012 Oct 30. Bioorg Med Chem. 2013. PMID: 23199485
Discovery of N-(3-Carbamoyl-5,5,7,7-tetramethyl-5,7-dihydro-4H-thieno[2,3-c]pyran-2-yl)-lH-pyrazole-5-carboxamide (GLPG1837), a Novel Potentiator Which Can Open Class III Mutant Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Channels to a High Extent.
Van der Plas SE, Kelgtermans H, De Munck T, Martina SLX, Dropsit S, Quinton E, De Blieck A, Joannesse C, Tomaskovic L, Jans M, Christophe T, van der Aar E, Borgonovi M, Nelles L, Gees M, Stouten P, Van Der Schueren J, Mammoliti O, Conrath K, Andrews M. Van der Plas SE, et al. Among authors: tomaskovic l. J Med Chem. 2018 Feb 22;61(4):1425-1435. doi: 10.1021/acs.jmedchem.7b01288. Epub 2018 Jan 10. J Med Chem. 2018. PMID: 29148763
Spirobipyridopyrans, spirobinaphthopyrans, indolinospiropyridopyrans, indolinospironaphthopyrans and indolinospironaphtho-1,4-oxazines: synthesis, study of X-ray crystal structure, antitumoral and antiviral evaluation.
Raić-Malić S, Tomasković L, Mrvos-Sermek D, Prugovecki B, Cetina M, Grdisa M, Pavelić K, Mannschreck A, Balzarini J, De Clercq E, Mintas M. Raić-Malić S, et al. Among authors: tomaskovic l. Bioorg Med Chem. 2004 Mar 1;12(5):1037-45. doi: 10.1016/j.bmc.2003.12.010. Bioorg Med Chem. 2004. PMID: 14980617
Engaging communities in tuberculosis research.
Boulanger RF, Seidel S, Lessem E, Pyne-Mercier L, Williams SD, Mingote LR, Scott C, Chou AY, Lavery JV; Critical Path to TB Drug Regimens' Stakeholder and Community Engagement Workgroup. Boulanger RF, et al. Lancet Infect Dis. 2013 Jun;13(6):540-5. doi: 10.1016/S1473-3099(13)70042-2. Epub 2013 Mar 24. Lancet Infect Dis. 2013. PMID: 23531390
Gaps in policy-relevant information on burden of disease in children: a systematic review.
Rudan I, Lawn J, Cousens S, Rowe AK, Boschi-Pinto C, Tomasković L, Mendoza W, Lanata CF, Roca-Feltrer A, Carneiro I, Schellenberg JA, Polasek O, Weber M, Bryce J, Morris SS, Black RE, Campbell H. Rudan I, et al. Among authors: tomaskovic l. Lancet. 2005 Jun 11-17;365(9476):2031-40. doi: 10.1016/S0140-6736(05)66697-4. Lancet. 2005. PMID: 15950717 Review.
11 results